Thomas Dolca
Insider CIK 1768239 · KDNY Director · PRNB Chief Medical Officer · ALLK Director · EQ Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALLK Allakos Inc. | D To issuer deriv | 2025-05-15 | 2025-05-15 | 154,786 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | D To issuer deriv | 2025-05-15 | 2025-05-15 | 41,000 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | A Award deriv | 2024-05-24 | 2024-05-29 | 41,000 | — | $0 | 41,000 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 23,522 | $25.23 | $593.5K | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 5,948 | $23.19 | $137.9K | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 13,300 | $26.12 | $347.4K | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer | 2023-08-11 | 2023-08-11 | 13,300 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | A Award deriv | 2023-08-01 | 2023-08-03 | 154,786 | — | $0 | 154,786 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | M Exercise deriv | 2023-05-26 | 2023-05-31 | 3,300 | — | $0 | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | M Exercise | 2023-05-26 | 2023-05-31 | 3,300 | — | $0 | 13,300 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | P Buy | 2022-09-02 | 2022-09-06 | 300 | $21.20 | $6.4K | 10,000 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | P Buy | 2022-09-02 | 2022-09-06 | 9,700 | $21.22 | $205.8K | 9,700 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | A Award deriv | 2022-05-26 | 2022-05-31 | 3,300 | — | $0 | 3,300 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | A Award deriv | 2022-05-26 | 2022-05-31 | 13,300 | — | $0 | 13,300 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | A Award deriv | 2021-06-04 | 2021-06-07 | 5,948 | — | $0 | 5,948 | SEC↗ |
| EQ Equillium, Inc. | A Award deriv | 2021-01-11 | 2021-01-13 | 450,000 | — | $0 | 450,000 | SEC↗ |
| KDNY ADURO BIOTECH, INC. | A Award deriv | 2020-10-06 | 2020-10-07 | 23,522 | — | $0 | 23,522 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 168,057 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 60,000 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 55,000 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | U Tender | 2020-09-28 | 2020-09-28 | 2,207 | $100.00 | $220.7K | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise deriv | 2020-08-18 | 2020-08-20 | 15,000 | — | $0 | 168,057 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-08-18 | 2020-08-20 | 15,000 | $100.00 | $1.50M | 1,826 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise | 2020-08-18 | 2020-08-20 | 15,000 | $23.77 | $356.6K | 16,826 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise deriv | 2020-07-15 | 2020-07-17 | 15,000 | — | $0 | 183,057 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise | 2020-07-15 | 2020-07-17 | 15,000 | $23.77 | $356.6K | 16,826 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-07-15 | 2020-07-17 | 15,000 | $80.07 | $1.20M | 1,826 | SEC↗ |
| PRNB Principia Biopharma Inc. | A Award deriv | 2020-03-05 | 2020-03-05 | 55,000 | — | $0 | 55,000 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2019-12-19 | 2019-12-20 | 495 | $60.00 | $29.7K | 494 | SEC↗ |
| PRNB Principia Biopharma Inc. | A Award deriv | 2019-03-01 | 2019-03-08 | 60,000 | — | $0 | 60,000 | SEC↗ |